[Rosiglitazone--statistics for benefits and problems]

MeSH terms

• Cardiovascular Diseases / chemically induced
• Diabetes Mellitus, Type 2 / drug therapy
• Humans
• Hypoglycemic Agents* / adverse effects
• Hypoglycemic Agents* / therapeutic use
• Meta-Analysis as Topic
• Randomized Controlled Trials as Topic
• Risk Factors
• Rosiglitazone
• Thiazolidinediones* / adverse effects
• Thiazolidinediones* / therapeutic use